1 |
Oh, S. Y., Jun, H. J and, Kim, S. C. (2002) Changin trends in the treatment of erectile dysfunction in the era of oral sildenafil. Korean J. Urol. 43: 69-74.
|
2 |
최형기 (2002) 발기부전치료의 새로운 PDE5 (phosphodiesterase 5) 억제제들. 약물요법, 1050-1056, 출판사명, 지명기입요망.
|
3 |
Pantel, J., Williams, S. Y., Mi, D., Sebag, J., Corbin, J. D., Weaver, C. D. and Cone, R. D. (2011) Development of a high throughput screen for allosteric modulators of melanocortin- 4 receptor signaling using a real time cAMP assay. Eur. J. Pharmacol. 660: 139-147.
DOI
ScienceOn
|
4 |
Chen, C. Y., Chang, Y. H., Bau, D. T., Huang, H. J., Tsai, F. J., Tsai, C. H. and Chen, C. Y. (2009) Discovery of potent inhibitors for phosphodiesterase 5 by virtual screening and pharmacophore analysis. Acta Pharmacol. Sin. 30: 1186- 1194.
DOI
ScienceOn
|
5 |
Chen, C. Y. (2009) Computational screening and design of traditional Chinese medicine (TCM) to block phosphodiesterase-5. J. Mol. Graph. Model. 28: 261-269.
DOI
ScienceOn
|
6 |
Ho, C. C. and Tan, H. M. (2011) Rise of herbal and traditional medicine in erectile dysfunction management. Curr. Urol. Rep. 12: 470-478.
DOI
ScienceOn
|
7 |
Zhang, J., Li, Y., Sun, J., Liu, C. and Zhang, D. (2011) Synergistic or antagonistic effect of MTE plus TF or icariin from Epimedium koreanum on the proliferation and differentiation of primary osteoblasts in vitro. Biol. Trace Elem. Res. 143: 1746-1757.
DOI
ScienceOn
|
8 |
Zhang, W., Wang, Y., Yang, Z., Qiu, J., Ma, J., Zhao, Z. and Bao, T. (2011) Antioxidant treatment with quercetin ameliorates erectile dysfunction in streptozotocin-induced diabeticrats. J. Biosci. Bioeng. 112: 215-218.
DOI
ScienceOn
|
9 |
Zamble, A., Carpentier, M., Kandoussi, A., Sahpaz, S., Petrault, O., Ouk, T., Hennuyer, N., Fruchart, J.C., Staels, B., Bordet, R., Duriez, P., Bailleul, F. and Martin-Nizard, F. (2006) Paullinia pinnata extracts rich in polyphenols promote vascular relaxation via endothelium-dependent mechanisms. J. Cardiovasc. Pharmacol. 47: 599-608.
DOI
ScienceOn
|
10 |
Hnatyszyn, O., Moscatelli, V., Rondina, R., Costa, M., Arranz, C., Balaszczuk, A., Coussio, J. and Ferraro, G. (2004) Flavonoids from Achyrocline satureioides with relaxant effects on the smooth muscle of Guinea pig corpus cavernosum. Phytomedicine 11: 366-369.
DOI
ScienceOn
|
11 |
Stanislavov, R. and Nikolova, V. (2003) Treatment of erectile dysfunction with pycnogenol and L-arginine. J. Sex Marital Ther. 29: 207-213.
DOI
ScienceOn
|
12 |
Drewes, S. E., Horn, M. M., Munro, O. Q., Dhlamini, J. T., Meyer, J. J. and Rakuambo N.C. (2002) Pyrano-isoflavones with erectile- dysfunction activity from Eriosema kraussianum. Phytochemistry 59: 739-747.
DOI
ScienceOn
|
13 |
Boswell-Smith, V., Spina, D. and Page, C. P. (2006) Phosphodiesterase inhibitors. Br. J. Pharmacol. 147 Suppl 1: S252-257.
|
14 |
Ahn, B. O., Ko, K. H., Oh, T. Y., Cho, H., Kim, W. B., Lee, K. J., Cho, S. W. and Hahm, K. B. (2001) Efficacy of use of colonoscopy in dextran sulfate sodium induced ulcerative colitis in rats: the evaluation of the effects of antioxidant by colonoscopy. Int. J. Colorectal. Dis. 16: 174-181.
DOI
ScienceOn
|
15 |
Li, Y. F., Huang, Y., Amsdell, S. L., Xiao, L., O'Donnell, J. M. and Zhang, H. T. (2009) Antidepressan and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus. Neuropsychopharmacology 34: 2404-2419.
DOI
ScienceOn
|
16 |
Field, S. K. (2011) Roflumilast, a novel phosphodiesterase 4 inhibitor, for COPD patients with a history of exacerbations. Clin. Med. Insights Circ. Respir. Pulm. Med. 5: 57-70.
|
17 |
Cheung, Y. F., Kan, Z., Garrett-Engele, P., Gall, I., Murdoch, H., Baillie, G. S., Camargo, L. M., Johnson, J. M., Houslay, M. D. and Castle J. C. (2007) PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform- specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6). J. Pharmacol. Exp. Ther. 322: 600-609.
DOI
ScienceOn
|
18 |
White, J. B., Thompson, W. J. and Pittler, S. J. (2004) Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6. Mol. Vis. 10: 738-749.
|
19 |
Smith, S. J., Cieslinski, L. B., Newton, R., Donnelly, L. E., Fenwick, P. S., Nicholson, A. G., Barnes, P. J., Barnette M. S. and Giembycz, M. A. (2004) Discovery of BRL 50481 [3- (N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: in vitro studies in human monocytes, lung macrophages, and CD8+ T-lymphocytes. Mol. Pharmacol. 66: 1679-1689.
DOI
ScienceOn
|
20 |
Jeremy, J. Y., Ballard, S. A., Naylor, A. M., Miller, M. A. and Angelini, G. D. (1997) Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro. Br. J. Urol. 79: 958-963.
DOI
|
21 |
Giuliano, F. (2002) PDE5 inhibition in erectile dysfunction : a overview. Eur. Heart. J. 4: H7-12.
DOI
|
22 |
Carson, C. C., Burnett, A. L., Levine, L. A. and Nehra, A. (2002) The efficacy of sildenafil citrate (Viagra) in clinical populations: an update. Urology 60: 12-27.
|
23 |
본초학 (2002) 한국생약교수협의회. 아카데미서적, 서울.
|
24 |
Braun, M., Wassmer, G., Klotz, T., Reifenrath, B., Mathers, M. and Engelmann, U. (2000) Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int. J. Impot. Res. 12: 305-311.
DOI
ScienceOn
|
25 |
Francis, S. H., Turko, I. V. and Corbin, J. D. (2001) Cyclic nucleotide phosphodiesterases: relating structure and function. Prog. Nucleic Acid Res. Mol. Biol. 65: 1-52.
|
26 |
Houslay, M. D. (2001) PDE4 cAMP-specific phosphodiesterases. Prog. Nucleic Acid Res. Mol. Biol. 69: 249-315.
|